SPD544 High Strength Bioequivalence Study

NCT01183234 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: SPD544
DRUG: Methylphenidate hydrochloride

Sponsor

Shire